These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 449359)

  • 1. Effect of preoperative intralesional BCG and postoperative 5-FU chemotherapy in three adenocarcinoma lines in rats.
    Lee YT
    J Surg Oncol; 1979; 11(4):295-304. PubMed ID: 449359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
    Lee YT
    Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant postoperative chemotherapy with 5-fluorouracil and methotrexate: effect of schedule of administration on metastasis of 13762 mammary adenocarcinoma.
    Lee YT; Khwaja TA
    J Surg Oncol; 1977; 9(5):469-79. PubMed ID: 592846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single versus double preoperative intralesional BCG in 13762 mammary adenocarcinoma.
    Lee YT
    J Surg Oncol; 1979; 12(3):243-52. PubMed ID: 502566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
    Greager JA; Baldwin RW
    Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584
    [No Abstract]   [Full Text] [Related]  

  • 6. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
    Kreider JW; Bartlett GL; Boyer CM; Purnell DM
    Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.
    Bogden AE; Esber HJ; Taylor DJ; Gray JH
    Cancer Res; 1974 Jul; 34(7):1627-31. PubMed ID: 4857731
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition or enhancement of rat mammary tumors dependent on dose BCG.
    Piessens WF; Campbell M; Churchill WH
    J Natl Cancer Inst; 1977 Jul; 59(1):207-11. PubMed ID: 875054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of surgery, irradiation, chemotherapy, and immunotherapy on growth of a metastasizing rat mammary adenocarcinoma.
    Bogden AE; Esber HJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):97-100. PubMed ID: 748802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy for colon adenocarcinoma: current status of clinical investigation.
    Köhne-Wömpner CH; Schöffski P; Schmoll HJ
    Ann Oncol; 1994; 5 Suppl 3():97-104. PubMed ID: 8204538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability of rat mammary adenocarcinoma 13762 as a model for BCG immunotherapy.
    Kreider JW; Bartlett GL; Purnell DM
    J Natl Cancer Inst; 1976 Apr; 56(4):797-802. PubMed ID: 815563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of BCG immunotherapy on kinetic parameters and growth curves of 5 transplantable lines of colon carcinoma chemically induced in rat (author's transl)].
    Martin MS; Martin F; Justrabo E; Michel MF; Lagneau A
    Gastroenterol Clin Biol; 1979 Mar; 3(3):247-53. PubMed ID: 456820
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant preoperative and postoperative immunochemotherapy for mammary adenocarcinoma in rats.
    Sparks FC; O'Connell TX; Lee YT
    Surg Forum; 1973; 24():118-21. PubMed ID: 4618633
    [No Abstract]   [Full Text] [Related]  

  • 16. Remission of metastatic adenocarcinoma of the colon.
    Shapiro CM; Bitran JD; Shapiro RA
    JAMA; 1983 Nov; 250(18):2503-4. PubMed ID: 6632141
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumor immunochemotherapy with 5-fluorouracil emulsion and BCG in C3H/HE mice transplanted with MH134.
    Sakita M; Kasuga M; Yamane T; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan; 1982 Dec; 73(6):931-7. PubMed ID: 6761229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical adjuvant immunotherapy for colorectal cancer.
    Enker WE; Jacobitz JL; Craft K; Wissler RW
    J Surg Oncol; 1978; 10(5):389-97. PubMed ID: 732327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of postoperative metastases of 13762A rat mammary adenocarcinoma: comparative effectiveness of BCG substrains and methods of preparation.
    Kreider JW; Bartlett GL; Purnell DM
    Cancer; 1980 Aug; 46(3):500-7. PubMed ID: 7397623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.